Title : Thalidomide reduces IL-18, IL-8 and TNF-alpha release from alveolar macrophages in interstitial lung disease.

Pub. Date : 2006 Oct

PMID : 16837501






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Thalidomide reduces IL-18, IL-8 and TNF-alpha release from alveolar macrophages in interstitial lung disease. Thalidomide C-X-C motif chemokine ligand 8 Homo sapiens
2 At the highest thalidomide concentration (0.1 mM), LPS-stimulated IL-8 production was also suppressed. Thalidomide C-X-C motif chemokine ligand 8 Homo sapiens
3 In IPF patients, although spontaneous production of TNF-alpha, IL-12p40, IL-18 and IL-8 was lower than in sarcoidosis and HP patients, with LPS stimulation the cytokines were significantly elevated and also partially inhibited by thalidomide. Thalidomide C-X-C motif chemokine ligand 8 Homo sapiens
4 In conclusion, thalidomide has the potential to improve the therapeutic regimens for sarcoidosis, hypersensitivity pneumonitis and idiopathic pulmonary fibrosis by reducing tumour necrosis factor-alpha, interleukin-12p40, interleukin-18 and interleukin-8 production. Thalidomide C-X-C motif chemokine ligand 8 Homo sapiens